Clinical Trial Update: Study to Evaluate Safety and Efficacy in Adult Subjects With ITP [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating safety and efficacy in adults with immune thrombocytopenic purpura completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenic Purpura

Drugs mentioned

• Bristol-Myers Squibb

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Immune Thrombocytopenic Purpura | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-01